Tue, 06 Dec 2016 17:39 GMTCaution ahead of OPEC meeting; drugmaker still hindered.
Tue, 06 Dec 2016 15:48 GMTWe believe KHC is in a sweet spot, and we want to turn to more traditional growth and forgotten areas.
Mon, 05 Dec 2016 17:53 GMTShares have reached our sweet spot.
Mon, 05 Dec 2016 13:44 GMTWe downgraded ratings on 3 positions and raised our price target on another.
Fri, 02 Dec 2016 22:59 GMTOPEC deal is among the highlights as markets finish off an explosive November. In the portfolio, we adjust the size of some of our positions.
Fri, 02 Dec 2016 19:07 GMTJohnson faces a daunting assignment in replacing CEO Schultz.
Fri, 02 Dec 2016 16:24 GMTContinued strength is likely the final stepping stone to a December rate hike, but questions linger.
Thu, 01 Dec 2016 19:29 GMTWe're moving with the market rotations.
Thu, 01 Dec 2016 16:17 GMTWe are encouraged by the overall sales results and the improving trends throughout the month.
Thu, 01 Dec 2016 14:25 GMTAnother look at our stock shopping list unveiled yesterday. Plus, a discussion of the OPEC deal and oil's market impact.
Wed, 30 Nov 2016 20:22 GMTWe'll purchase more shares of these 2 names as we keep our eye on ignored sectors.
Wed, 30 Nov 2016 20:15 GMTWe're adding Apache, Altria and Thermo Fisher to our Bullpen.
Wed, 30 Nov 2016 16:06 GMTWe are pleasantly surprised by the larger-than-anticipated oil-production cut announcement, but we await clarity and confirmation before making any big move.
Tue, 29 Nov 2016 21:10 GMTUltimately, the DirecTV Now unveiling resulted in a sigh of relief among investors.
Tue, 29 Nov 2016 16:26 GMTEmbattled name has gained in recent bank rally.
Mon, 28 Nov 2016 17:00 GMTWe'll sell half our position as the company faces 3 discrete headwinds.
Fri, 25 Nov 2016 20:49 GMTThe markets reach record highs in a short week as oil and a potential rate hike get much of the attention.
Thu, 24 Nov 2016 00:49 GMTHewlett Packard Enterprise results provide motivation.
Tue, 22 Nov 2016 22:12 GMTThese companies should be owned for the long term.
Tue, 22 Nov 2016 19:40 GMTWe'll buy more Allergan shares, with the risk-reward skewed heavily to the upside.